Cargando…
A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma
SIMPLE SUMMARY: We investigated the feasibility and immunogenicity of an autologous Dendritic Cell (DC) vaccine pulsed with peptide neoantigens in combination with a standard of care regimen. The vaccine program took place in a serous endometrial mismatch repair (MMR) deficiency setting. We demonstr...
Autores principales: | Harari, Alexandre, Sarivalasis, Apostolos, de Jonge, Kaat, Thierry, Anne-Christine, Huber, Florian, Boudousquie, Caroline, Rossier, Laetitia, Orcurto, Angela, Imbimbo, Martina, Baumgaertner, Petra, Bassani-Sternberg, Michal, Kandalaft, Lana E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616532/ https://www.ncbi.nlm.nih.gov/pubmed/34830955 http://dx.doi.org/10.3390/cancers13225801 |
Ejemplares similares
-
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma
por: Sarivalasis, Apostolos, et al.
Publicado: (2019) -
Sensitive identification of neoantigens and cognate TCRs in human solid tumors
por: Arnaud, Marion, et al.
Publicado: (2021) -
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors
por: Schmidt, Julien, et al.
Publicado: (2023) -
Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human
por: Chiang, Cheryl Lai-Lai, et al.
Publicado: (2021) -
Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines
por: Graciotti, Michele, et al.
Publicado: (2020)